Cargando…

Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles

A novel biologically active organic ligand L (N’-benzylidenepyrazine-2-carbohydrazonamide) and its three coordination compounds have been synthesized and structurally described. Their physicochemical and biological properties have been thoroughly studied. Cu(II), Zn(II), and Cd(II) complexes have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Czylkowska, Agnieszka, Rogalewicz, Bartłomiej, Szczesio, Małgorzata, Raducka, Anita, Gobis, Katarzyna, Szymański, Paweł, Czarnecka, Kamila, Camargo, Bruno Cury, Szczytko, Jacek, Babich, Alexey, Dubkov, Sergey, Lazarenko, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950742/
https://www.ncbi.nlm.nih.gov/pubmed/35328401
http://dx.doi.org/10.3390/ijms23062980
_version_ 1784675216010510336
author Czylkowska, Agnieszka
Rogalewicz, Bartłomiej
Szczesio, Małgorzata
Raducka, Anita
Gobis, Katarzyna
Szymański, Paweł
Czarnecka, Kamila
Camargo, Bruno Cury
Szczytko, Jacek
Babich, Alexey
Dubkov, Sergey
Lazarenko, Petr
author_facet Czylkowska, Agnieszka
Rogalewicz, Bartłomiej
Szczesio, Małgorzata
Raducka, Anita
Gobis, Katarzyna
Szymański, Paweł
Czarnecka, Kamila
Camargo, Bruno Cury
Szczytko, Jacek
Babich, Alexey
Dubkov, Sergey
Lazarenko, Petr
author_sort Czylkowska, Agnieszka
collection PubMed
description A novel biologically active organic ligand L (N’-benzylidenepyrazine-2-carbohydrazonamide) and its three coordination compounds have been synthesized and structurally described. Their physicochemical and biological properties have been thoroughly studied. Cu(II), Zn(II), and Cd(II) complexes have been analyzed by F-AAS spectrometry and elemental analysis. The way of metal–ligand coordination was discussed based on FTIR spectroscopy and UV-VIS-NIR spectrophotometry. The thermal behavior of investigated compounds was studied in the temperature range 25–800 °C. All compounds are stable at room temperature. The complexes decompose in several stages. Magnetic studies revealed strong antiferromagnetic interaction. Their cytotoxic activity against A549 lung cancer cells have been studied with promising results. We have also investigated the biological effect of coating studied complexes with silver nanoparticles. The morphology of the surface was studied using SEM imaging.
format Online
Article
Text
id pubmed-8950742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89507422022-03-26 Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles Czylkowska, Agnieszka Rogalewicz, Bartłomiej Szczesio, Małgorzata Raducka, Anita Gobis, Katarzyna Szymański, Paweł Czarnecka, Kamila Camargo, Bruno Cury Szczytko, Jacek Babich, Alexey Dubkov, Sergey Lazarenko, Petr Int J Mol Sci Article A novel biologically active organic ligand L (N’-benzylidenepyrazine-2-carbohydrazonamide) and its three coordination compounds have been synthesized and structurally described. Their physicochemical and biological properties have been thoroughly studied. Cu(II), Zn(II), and Cd(II) complexes have been analyzed by F-AAS spectrometry and elemental analysis. The way of metal–ligand coordination was discussed based on FTIR spectroscopy and UV-VIS-NIR spectrophotometry. The thermal behavior of investigated compounds was studied in the temperature range 25–800 °C. All compounds are stable at room temperature. The complexes decompose in several stages. Magnetic studies revealed strong antiferromagnetic interaction. Their cytotoxic activity against A549 lung cancer cells have been studied with promising results. We have also investigated the biological effect of coating studied complexes with silver nanoparticles. The morphology of the surface was studied using SEM imaging. MDPI 2022-03-10 /pmc/articles/PMC8950742/ /pubmed/35328401 http://dx.doi.org/10.3390/ijms23062980 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Czylkowska, Agnieszka
Rogalewicz, Bartłomiej
Szczesio, Małgorzata
Raducka, Anita
Gobis, Katarzyna
Szymański, Paweł
Czarnecka, Kamila
Camargo, Bruno Cury
Szczytko, Jacek
Babich, Alexey
Dubkov, Sergey
Lazarenko, Petr
Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title_full Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title_fullStr Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title_full_unstemmed Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title_short Antitumor Activity against A549 Cancer Cells of Three Novel Complexes Supported by Coating with Silver Nanoparticles
title_sort antitumor activity against a549 cancer cells of three novel complexes supported by coating with silver nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950742/
https://www.ncbi.nlm.nih.gov/pubmed/35328401
http://dx.doi.org/10.3390/ijms23062980
work_keys_str_mv AT czylkowskaagnieszka antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT rogalewiczbartłomiej antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT szczesiomałgorzata antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT raduckaanita antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT gobiskatarzyna antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT szymanskipaweł antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT czarneckakamila antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT camargobrunocury antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT szczytkojacek antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT babichalexey antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT dubkovsergey antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles
AT lazarenkopetr antitumoractivityagainsta549cancercellsofthreenovelcomplexessupportedbycoatingwithsilvernanoparticles